A concise synthesis of fumagillol

Angewandte Chemie - International Edition

Volumn 38, Issue 7, 1999, Pages 971-974

  Vosburg, David A ^a   Weiler, Sven ^a   Sorensen, Erik J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Antitumor agents; Fumagillin; Natural products; Total synthesis

Indexed keywords

FUMAGILLIN; FUMAGILLOL; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANTIPROTOZOAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0033119793     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19990401)38:7<971::AID-ANIE971>3.0.CO;2-W     Document Type: Article

References (43)

1. F. R. Hanson, E. Eble, J. Bact. 1949, 58, 527-529.
2. a) M. C. McCowen, M. E. Callender, J. F. Lawlis, Jr., Science 1951, 112, 202-203;
3. b) H. Katznelson, C. A. Jamieson, Science 1952, 115, 70-71;
4. c) J. H. Killough, G. B. Magill, R. C. Smith, Science 1952, 115, 71-72.
5. a) D. S. Tarbell, R. M. Carman, D. D. Chapman, S. E. Cremer, A. D. Cross, K. R. Huffman, M. Kunstmann, N. J. McCorkindale, J. G. McNally, Jr., A. Rosowsky, F. H. L. Varino, R. L. West, J. Am. Chem. Soc. 1961, 83, 3096-3113, and references therein;
6. b) J. R. Turner, D. S. Tarbell, Proc. Natl. Acad. Sci. USA 1962, 48, 733-735.
7. N. J. McCorkindale, J. G. Sime, Proc. Chem. Soc. 1961, 331.
8. For early attempts to achieve a synthesis of fumagillin, see a) S. T. Young, J. R. Turner, D. S. Tarbell, J. Org. Chan. 1963, 28, 928-932;
9. b) G. Büchi, J. E. Powell, Jr., J. Am. Chem. Soc. 1970, 92, 3126-3133.
10. a) E. J. Corey, B. B. Snider, J. Am. Chem. Soc. 1972, 94, 2549-2550;
11. b) B. B. Snider, PhD Thesis, Harvard University, 1973.
12. For a recent 26-step synthesis of (-)-fumagillol, see D. Kim, S. K. Ahn, H. Bae, W. J. Choi, H. S. Kim, Tetrahedron Lett. 1997, 38, 4437-4440.
13. D. Ingber, T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem, J. Folkman, Nature 1990, 348, 555-557.
14. a) J. Folkman, New Engl. J. Med. 1971, 285, 1182-1186;
15. b) J. Folkman, New Engl. J. Med. 1995, 333, 1757-1763;
16. c) J. Folkman, Nat. Med. 1995, 1, 27-31;
17. d) A. Giannis, F. Rübsam, Angew. Chem. 1997, 109, 606-609;
18. Angew. Chem. Int. Ed. Engl. 1997, 36, 588-590;
19. e) J. Taunton, Chem. Biol. 1997, 4, 493-496.
20. N. Sin, L. Meng, M. Q. W. Wang, J. J. Wen, W. G. Bornmann, C. M. Crews, Proc. Natl. Acad. Sci. USA 1997, 94, 6099-6103.
21. E. C. Griffith, Z. Su, B. E. Turk, S. Chen, Y.-H. Chang, Z. Wu, K. Biemann, J. O. Liu, Chem. Biol. 1997, 4, 461-471.
22. Very recently, Clardy and co-workers reported an X-ray crystal structure of human MetAP-2 covalently bound by fumagillin, see S. Liu, J. Widom, C. W. Kemp, C. M. Crews, J. Clardy, Science 1998, 252, 1324-1327.
23. See also W. T. Lowther, D. A. McMillen, A. M. Orville, B. W. Matthews, Proc. Natl. Acad. Sci. USA 1998, 95, 12153-12157.
24. For a recent review of protein myristoylation, see J. A. Boutin, Cell. Signalling 1997, 9, 15-35.
25. T. Yoshida, Y. Kaneko, A. Tsukamoto, K. Han, M. Ichinose, S. Kimura, Cancer Res. 1998, 58, 3751-3756.
26. For a scholarly review of substrate-directable chemical reactions, see A. H. Hoveyda, D. A. Evans, G. C. Fu, Chem. Rev. 1993, 93, 1307-1370.
27. V. Van Rheenen, R. C. Kelly, D. Y. Cha, Tetrahedron Lett. 1976, 1973-1976.
28. W. Langenbeck, O. Godde, L. Weschky, R. Schaller, Ber. Dtsch. Chem. Ges. 1942, 75, 232-236.
29. 1-Diethylamino-1,3-butadiene can be prepared on a large scale in one step from diethylamine and crotonaldehyde, see S. Hünig, H. Kahanek, Chem. Ber. 1957, 90, 238-245.
30. Woodward's landmark synthesis of reserpine provides instructive, early instances of this tactic, see R. B. Woodward, F. E. Bader, A. J. Frey, R. W. Kierstead, Tetrahedron 1958, 2, 1-57.
31. Vinyl bromide 8 was prepared by a slight modification of the excellent one-flask procedure of Corey et al., see E. J. Corey, J. Lee, B. E. Roberts, Tetrahedron Lett. 1997, 38, 8915-8918.
32. See also E. J. Corey, J. P. Dittami, J. Am. Chem. Soc. 1985, 107, 256-257.
33. For the use of Li(2-thienyl)CuCN, see B. H. Lipshutz, M. Koerner, D. A. Parker, Tetrahedron Lett. 1987, 28, 945-948.
34. For reviews of the conjugate addition chemistry of organocuprates, see a) B. H. Lipshutz, S. Sengupta, Org. React. 1992, 41, 135-631;
35. b) J. A. Kozlowski in Comprehensive Organic Synthesis, Vol. 1 (Eds.: B. M. Trost, I. Fleming, S. L. Schreiber), Pergamon, New York, 1991, pp. 169-198.
36. 2, followed by fluoride-induced cleavage of the crude enol silyl ethers.
37. a) C. H. Cummins, R. M. Coates, J. Org. Chem. 1983, 48, 2070-2076;
38. b) R. M. Coates, C. H. Cummins, J. Org. Chem. 1986, 51, 1383-1389.
39. K. B. Sharpless, R. C. Michaelson, J. Am. Chem. Soc. 1973, 95, 6136-6137.
40. While our studies were underway, a closely related transformation was described, see S. Amano, N. Ogawa, M. Ohtsuka, S. Ogawa, N. Chida, Chem. Commun. 1998, 1263-1264.
41. This is a slight modification of a procedure employed in Corey and Snider's pioneering synthesis of fumagillin (reference [6]).
42. 2Me) in optically active form is available from (-)-quinic acid (D. F. McComsey, B. E. Maryanoff, J. Org. Chem. 1994, 59, 2652-2654) or by Sharpless asymmetric dihydroxylation followed by isopropylidene ketal formation
43. (Z.-M. Wang, K. Kakiuchi, K. B. Sharpless, J. Org. Chem. 1994, 59, 6895-6897).